All

MaaT Pharma announces €10 million fundraising and pursues the development of the first worldwide autologous microbiotherapy solution
22 March 2016

MaaT Pharma announces €10 million fundraising and pursues the development of the first worldwide autologous microbiotherapy solution

MaaT Pharma, a reference for the microbiome industry, is announcing a significant €10 million fundraising operation within the context of its series A. This will notably...

Read the press release
Digital Technologies Department of Seventure Partners announces CONJECT Holding GmbH acquisition by ACONEX Ltd.
17 March 2016

Digital Technologies Department of Seventure Partners announces CONJECT Holding GmbH acquisition by ACONEX Ltd.

The Digital Technologies Department of Seventure Partners, leading venture capital firm in Europe for innovation funding, today announces the selling of CONJECT Holding GmbH, a...

Read the press release
Mailjet Raises $11 Million Series B to Expand Marketing and Transactional Email Deliverability
15 July 2015

Mailjet Raises $11 Million Series B to Expand Marketing and Transactional Email Deliverability

Mailjet, the all-in-one email service provider, today announced a $11M Series B funding round, led by Iris Capital, with returning investor Alven Capital and new investor...

Read the press release
TxCell announces start of phase IIb clinical trial with Ovasave® for refractory Crohn’s disease
4 December 2014

TxCell announces start of phase IIb clinical trial with Ovasave® for refractory Crohn’s disease

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing novel and innovative, cost-effective personalized T cell immunotherapies using antigen specific regulatory...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse